Radiomic markers associated with clinical benefit in patients with radiographic progression of advanced uveal melanoma on tebentafusp
European Journal of Cancer · 2025
DOI: 10.1016/j.ejca.2025.115386 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Volkan Beylergil und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Columbia University Medical Center/NewYork-Presbyterian Hospital, 161 Fort Washington Avenue, New York, NY 10032, USA. Hauptthemen laut MEDLINE: Melanoma, Recombinant Fusion Proteins, Uveal Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: RSNA Research and Educational Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Columbia University Medical Center/NewYork-Presbyterian Hospital, 161 Fort Washington Avenue, New York, NY 10032, USA.
- Immunocore, 92 Park Drive, Milton Park, Abingdon, Oxfordshire OX14 4RY, United Kingdom.
- Gustave Roussy, Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP), 114 Rue Edouard Vaillant, Villejuif 94805, France.
- Immunocore, 9801 Washingtonian Boulevard, Suite 800, Gaithersburg, MD 20878, USA.
- Department of Radiology, Columbia University Medical Center/NewYork-Presbyterian Hospital, 161 Fort Washington Avenue, New York, NY 10032, USA. Electronic address: ld2752@cumc.columbia.edu.
Förderung
- RSNA Research and Educational Foundation
Zitieren
APA
Beylergil, V., Collins, L., Schwartz, L. H., Eche, T., Zhao, B., Champiat, S., Carvajal, R., Abedin, S. E., & Dercle, L. (2025). Radiomic markers associated with clinical benefit in patients with radiographic progression of advanced uveal melanoma on tebentafusp. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.115386
Vancouver
Beylergil V, Collins L, Schwartz LH, Eche T, Zhao B, Champiat S, et al. Radiomic markers associated with clinical benefit in patients with radiographic progression of advanced uveal melanoma on tebentafusp. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.115386
BibTeX
@article{Beylergil2025,
author = {Beylergil, Volkan and Collins, Laura and Schwartz, Lawrence H and Eche, Thomas and Zhao, Binsheng and Champiat, Stephane and Carvajal, Richard and Abedin, Shaad E and Dercle, Laurent},
title = {Radiomic markers associated with clinical benefit in patients with radiographic progression of advanced uveal melanoma on tebentafusp},
journal = {European Journal of Cancer},
year = {2025},
doi = {10.1016/j.ejca.2025.115386}
}
EUVIMED